FORA Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,197
Closed -$1.1M 472
2026
Q1
$1.1M Sell
1,197
-91
-7% -$92.3K 0.08% 225
2025
Q4
$1.38M Sell
1,288
-339
-21% -$324K 0.17% 154
2025
Q3
$1.24M Buy
+1,627
New +$1.21M 0.22% 120
2023
Q4
Sell
-14,614
Closed -$7.85M 545
2023
Q3
$7.85M Buy
+14,614
New +$7.53M 0.69% 31
2023
Q1
Sell
-15,506
Closed -$5.67M 623
2022
Q4
$5.67M Buy
15,506
+6,751
+77% +$2.39M 0.92% 19
2022
Q3
$2.83M Buy
+8,755
New +$2.77M 0.54% 41
2022
Q2
Sell
-11,229
Closed -$3.25M 577
2022
Q1
$3.25M Buy
11,229
+9,297
+481% +$2.39M 0.59% 42
2021
Q4
$534K Sell
1,932
-11,636
-86% -$2.95M 0.21% 139
2021
Q3
$3.13M Sell
13,568
-1,329
-9% -$328K 0.79% 28
2021
Q2
$3.42M Buy
14,897
+9,613
+182% +$1.93M 0.64% 27
2021
Q1
$987K Buy
+5,284
New +$1.03M 0.32% 62
2020
Q3
Sell
-15,046
Closed -$2.47M 841
2020
Q2
$2.47M Buy
+15,046
New +$2.31M 0.85% 13

Other funds holding LLY

FORA Capital's LLY Position: Q2 2026 in Review

FORA Capital sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 1,197 shares — an estimated $1.1M sold.

FORA Capital first reported a position in LLY in Q2 2020 and held it in 12 quarters. The position peaked at $7.85M in Q3 2023. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • FORA Capital reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
  • FORA Capital sold 1,197 Eli Lilly shares in Q2 2026, an estimated $1.1M.
  • FORA Capital first reported a position in Eli Lilly in Q2 2020 and held it in 12 quarters.
  • FORA Capital's Eli Lilly position peaked at $7.85M in Q3 2023.
  • 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on FORA Capital's 13F filing for Q2 2026, filed 13 Aug 2026.